November is…

About Alzheimer's Disease (AD)
Alzheimer's Disease (AD) is a gradually progressive dementia characterized by loss of cholinergic neurons in the Central Nervous System (CNS). It affects approximately 4.5 million Americans, and is the most common cause of dementia. The greatest risk factor for AD is increasing age, affecting 53% of those between the age of 75 and 84. Onset may occur as early as age 40 (early-onset) but is more common after age 65 (lateonset AD). The etiology of AD is unknown, so current therapies do not cure or stop disease progression. The most important interventions for AD are nondrug therapy and social support for the patient and family members. 1 
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HEED THE WARNINGS!!
There are 10 warning signs identified by the Alzheimer's Association that may indicate early AD. These signs are different from typical age related changes in that they are much more severe or frequent than age-related changes in mental capability or cognitive function. 
Screening tools
This table provides a brief summary of the screening tools used to test for AD. As there is no way to diagnose Alzheimer's Disease in the absence of a brain biopsy, clinicians rely on tools such as the MMSE and clock scores to help them diagnose. 
Name of Measurement
Non-pharmacologic treatments
Current non-pharmacologic treatments for the management of AD are aimed at helping with sleep disturbances, wandering, urinary incontinence, agitation, and aggression. These include:
 Maintaining regular times for meals, bed time and waking  Seek morning sunlight exposure  Avoid alcohol, nicotine and caffeine  Regular daily exercise no later than 4 hours prior to bedtime  Avoid giving cholinesterase inhibitors before bed  Discourage lying in bed if the person is awake These measures are designed to alleviate some of the common issues related to Alzheimer's disease, but are not a substitute for pharmacologic therapy for treating the underlying disease process.
Herbal Remedies
Some common herbal remedies touted to help manage AD include gingko biloba, vitamin E and Huperzine A.  Gingko Biloba: Ginkgo interacts with the CYP system so there is high potential for drug interactions and it has been shown to increase the risk for bleeding when coadministered with other antiplatelet drugs. Ginkgo is perhaps the most widely studied herbal remedy for AD and is shown to have some modest benefit in improving cognition in patients with AD. However, its effects are less as the disease progresses 1,2 .
 Huperzine A: Due to its cholinesterase-like mechanism of action, this herbal should not be used along with prescription therapy for Alzheimer's disease. Studies with huperzine A have only been conducted in China and those studies did not find a conclusive role for huperzine A in the treatment of the disease despite its unique mechanism of action relative to other herbal remedies for AD 1, 3 .
 Vitamin E (tocopherol): Vitamin E may interact with warfarin and statins causing serious side effects. In studies, some correlation is seen between AD and low serum vitamin E levels. However, studies show no significant improvements in cognitive function in patients treated with 2000 units per day compared to those treated with donepezil or placebo 1, 3 . o This review article examines novel enzymes responsible for amyloid plaque formation and degradation. It further describes ways in which these key enzymes may be used as a pharmacologic target in the treatment of AD.
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